Mexico - Average costs (US$), effects and cost-effectiveness of breast cancer control scenarios per year.

aAll costs in this table are in 2009 US$ (1MXN = 0,0765697 US$).
bDALYs, disability-adjusted life-years (age weighted, discounted).
cACER: Average cost-effectiveness ratio compared to the do nothing-scenario (US$ per DALY averted).
dICER: Incremental cost effectiveness ratio, ratio of additional cost per additional life-year saved when next intervention is added to a mix on the intervention path (additional US$ per additional DALY saved).